IP Library Granted Patent US 10,350,049
Granted Patent B2
US 10,350,049 · App. 13/984,843 · Granted Jul 16, 2019

Laminated tissue grafts composed of Wharton's jelly and methods of making and using the same

Inventors: Brenda S. Morse (Marietta, GA); Somaly Sith (Marietta, GA); Randall Spencer (Marietta, GA); John Daniel (Marietta, GA); Robert Tofe (Denver, CO)
Assignee: MiMedx Group, Inc.
A61F2/02A61L27/3604A61L27/3683A61L27/50A61L2430/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,350,049
App. No.
13/984,843
Granted
Jul 16, 2019
Kind
B2
Abstract

Described herein are tissue grafts derived from the placenta with improved physical and biological properties. In one aspect, the tissue graft includes a first membrane comprising Wharton's jelly laminated with amnion, chorion, or a combination thereof. The presence of Wharton's jelly in the grafts enhances the performance of allograft amniotic-derived, caderivic allograft, xenograft, or alloplast soft tissue substitutes.

Claims (20)

1. A tissue graft comprising a first layer, a second layer, and a third layer laminated together, said first layer comprising a placental amnion, said second layer comprising a chorion, and said third layer comprising Wharton's jelly,

wherein the amnion comprises an exposed basement membrane and an amnion stromal layer, wherein the amnion stromal layer is adjacent to the chorion, and wherein the chorion comprises a chorion stromal layer, wherein the chorion stromal layer is adjacent to the Wharton's jelly,

wherein an intermediate layer of said amnion has not been substantially removed.

2. The graft of claim 1 , wherein the graft is substantially dry prior to use.

3. The graft of claim 2 which has been hydrated.

4. The graft of claim 1 , wherein the graft is hydrated with an aqueous solution comprising naturally occurring growth factors sourced from platelet concentrates, either using autologous blood collection and separation products, or xenograft sources that comprise fetal swine teeth and blood concentrates, purified natural bioactive agents, recombinant biological modifiers that comprise recombinant platelet derived growth factor and recombinant fibroblast growth factor, or any combination thereof.

5. The graft of claim 1 , wherein the graft is about 1 mm in thickness.

6. The graft of claim 1 , wherein the graft comprises laminin and laminin-5.

7. The graft of claim 1 , wherein the graft is soaked in platelet concentrates prior to use, said platelet concentrates sourced from expired banked blood.

8. The graft of claim 1 , wherein the graft is soaked with a bioactive agent comprising naturally occurring growth factors sourced from platelet concentrates, using autologous blood collection and separation products; bioactive agents sourced from allograft placentas; bone marrow aspirate; a solution of purified natural bioactive agents, recombinant bioactive agents, or any combination thereof.

9. The graft of claim 1 , wherein the amnion and chorion are obtained from a mammal other than a human.

10. A method for facilitating vascularization of a wound and promoting wound healing, the method comprising contacting the wound site with the graft of claim 1 .

11. A method for facilitating cell migration of gingival epithelia cells and promoting attachment of gingival epithelia cells to a tooth root, the method comprising contacting the gingival epithelia cells with the graft of claim 1 .

12. A method for promoting wound healing associated with a dental surgical procedure, comprising contacting the wound with the graft of claim 1 .

13. A method for preventing or reducing scar formation on or near the spine after a surgical procedure, the method comprising applying to a subject the tissue graft of claim 1 directly to the spinal dura of the subject or a region near the spine.

14. A method for treating a dural tear in a subject, the method comprising applying directly to the dural tear the tissue graft of claim 1 .

15. A method for promoting wound healing associated with an orthopedic application, associated with an ENT application, involving a subject's extremities, associated with an ophthalmological application, associated with a gynecological application, associated with an urological application, or associated with general surgery, wherein the method comprises contacting the wound with the graft of claim 1 .

16. A method for promoting wound healing in the human mucosa in the oral cavity, nose, throat, vagina, or rectum, the method comprising contacting the wound site with the graft of claim 1 .

17. A method for promoting the healing of a wound in a subject, the method comprising applying to the wound the graft of claim 1 , wherein the wound is in the cranial dura, a wound resulting from a perioplastic procedure, a frenum pull, in a patella, in a Schneiderian membrane in the sinus cavity, or is in soft tissue around a dental implant.

18. A method for preventing or reducing scar formation on or near a wound, the method comprising applying to the wound the graft of claim 1 .

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2024
From: HAYFIN SERVICES LLP
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 066493/0322 →
SECURITY INTEREST Recorded Jan 25, 2024
From: MIMEDX GROUP, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 066371/0136 →
SECURITY INTEREST Recorded Jan 25, 2024
From: MIMEDX GROUP, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 066250/0132 →
RELEASE OF SECURITY INTEREST Recorded Jul 2, 2020
From: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 054075/0687 →
PATENT SECURITY AGREEMENT Recorded Jul 2, 2020
From: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 053121/0833 →
SECURITY INTEREST Recorded Jun 11, 2019
From: MIMEDX GROUP, INC.
To: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 049426/0863 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 24, 2019
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: MIMEDX GROUP, INC.
Reel/Frame 048121/0835 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Oct 15, 2015
From: MIMEDX GROUP, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036872/0498 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2014
From: SURGICAL BIOLOGICS, LLC
To: MIMEDX GROUP, INC.
Reel/Frame 034034/0968 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2014
From: TOFE, ROBERT
To: SNOASIS MEDICAL, INC.
Reel/Frame 033275/0368 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2014
From: SNOASIS MEDICAL, INC.
To: SURGICAL BIOLOGICS, LLC
Reel/Frame 033275/0362 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2014
From: MORSE, BRENDA S.; SITH, SOMALY; SPENCER, RANDALL; DANIEL, JOHN
To: MIMEDX GROUP, INC.
Reel/Frame 033275/0352 →
Continuity (2)
Provisional Application 61442343 · Feb 14, 2011
Related Publication 20140343688A1 · Nov 20, 2014
Cited By (2)
US 12,208,180 US 12,376,843